SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gliatech (GLIA)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
2001 20 0 GLIA
Emcee:  scaram(o)uche Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1201 The shorts are working and sweating their butts off, trying to hold this suckerscaram(o)uche-1/20/2000
1200 Thursday January 20, 12:56 pm Eastern Time Company Press Release SOURCE: The scaram(o)uche-1/20/2000
1199 GLIA is a component of "2000", correcting for incorrect KDUS feed, upscaram(o)uche-1/20/2000
1198 Thanks, Harry. I agree with you, but.... as of H&Q, it sounded as though scaram(o)uche-1/20/2000
1197 Rick; FWIW it's worth, my timeline would be: 1) With the Phase II ADD triNeuroInvestment-1/20/2000
1196 <i>2000 objectives..... Approval for -L in Japan (Chugai). Begin U.S. mascaram(o)uche-1/19/2000
1195 Thanks. From the Reuters story regarding the upgrade...... "Jan 19 (Reutscaram(o)uche-1/19/2000
1194 GLIA upgraded by Prudential from Hold to Strong BuyD.Lu-1/19/2000
1193 HI perhaps this will intrest you also Complement receptor type 2 (CD21, CR2), dalroi-1/19/2000
1192 Rick and Peter, Thanks. C3, that's what I wanted to know. I did get off biowa-1/19/2000
1191 biowa, For a pretty-internet-picture view of the complement cascade, check outBiomaven-1/19/2000
1190 Classical answer.... alternative, early..... stabilizes C3 convertase. Indiscaram(o)uche-1/18/2000
1189 Rick, Lazy science on my part, but any idea where <i>complement protein biowa-1/18/2000
1188 Harry Tracy has a release out today........ Tuesday January 18, 10:02 am Eastescaram(o)uche-1/18/2000
1187 Tuesday January 18, 8:00 am Eastern Time Company Press Release SOURCE: Abgeniscaram(o)uche-1/18/2000
1186 <OK - Yahoo posters opine that GLIA will face similar difficulty in future aLLCF-1/14/2000
1185 I just read the TechVest comments (thanks, WD). Silly. Do they really think Fscaram(o)uche-1/14/2000
1184 >> The study design that GLIA is using for Adcon P is not collecting the scaram(o)uche-1/14/2000
1183 First a couple of points. I am in no way an expert on Adcon P's PMA designMike-1/13/2000
1182 Generally, it is my belief that the Yahoos can't tell Adcon from KY. RWRRWReeves-1/13/2000
1181 I haven't read the Yahoo! posts in question, but it seems a silly explanatiRussian Bear-1/13/2000
1180 OK - Yahoo posters opine that GLIA will face similar difficulty in future approClouseau-1/13/2000
1179 I don't get it. LCBM panel disapproval recc; GLIA down. What gives? FactoryClouseau-1/13/2000
1178 Reuters on FDA/LCBM (edited dup out - eom)sim1-1/12/2000
1177 More on FDA/LCBM rejection... Wednesday January 12, 7:17 pm Eastern Time FDA sim1-1/12/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):